JOSEPH PIEPRZYCA: Open Payments
NPI 1114221389 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,448 in 38 payments from 13 companies in 2025. Trend: 2023 $216 · 2024 $938 · 2025 $1,448
Food & beverage: $1,349Education: $99
| Company | Payments | Amount |
|---|---|---|
| Teleflex LLC | 3 | $366 |
| Janssen Biotech, Inc. | 4 | $276 |
| Sumitomo Pharma America, Inc. | 9 | $181 |
| ABBVIE INC. | 8 | $170 |
| Medtronic, Inc. | 2 | $112 |
| UROGEN PHARMA, INC. | 2 | $102 |
| Ferring Pharmaceuticals Inc. | 3 | $75 |
| ConvaTec Inc. | 2 | $74 |
| Myriad Genetic Laboratories, Inc. | 1 | $21 |
| Olympus America Inc. | 1 | $21 |
Products named: BARRIGEL, GEMTESA, ERLEADA, BOTOX, RYBREVANT, INTERSTIM, ADSTILADRIN, CURE CATHETER.
Industry payments across CA — which companies pay providers there.
